Priya Mehta

2PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 30, 2025
Favorable Outcome and Safety of Neoadjuvant Trastuzumab Emtansine (T-DM1) in a HER2-Positive Early Breast Cancer Patient with Severe Renal Disease on Hemodialysis Ineligible for Conventional Chemotherapy: A Case Report.

Suman Kalyan Natarajan, Joice Crystal Danansezhian, Vipulkumar Thummar

|Dec 05, 2022
Addition of trastuzumab emtansine (T-DM1) in a human epidermal growth factor receptor 2-overexpressed metastatic carcinoma of the gallbladder patient to enhance survival: A case study.

Viraj Lavingia, Vipulkumar Thummar, Priya Mehta

Pageof 1

Frequent Collaborators

1 joint publications

Suman Kalyan Natarajan